Evidence map›Paper›PMID 26299645›Full record

ArticleAnalytical biochemistry2015

Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA.

Lyudmyla G Glushakova, Nidhi Sharma, Shuichi Hoshika, Andrea C Bradley, Kevin M Bradley, Zunyi Yang, Steven A Benner

Abstract readValidation Study
In one paragraph

Article in Analytical biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Eight-Letter DNA.Biochemistry · 2019
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lyudmyla G GlushakovaFirebird Biomolecular Sciences, Alachua, FL 32615, USA.
Nidhi SharmaFoundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA.
Shuichi HoshikaFoundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA.
Andrea C BradleyFoundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA.
Kevin M BradleyFoundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA.
Zunyi YangFoundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA.
Steven A BennerFirebird Biomolecular Sciences, Alachua, FL 32615, USA; Foundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA. Electronic address: sbenner@ffame.org.
Foundation for Applied Molecular Evolution · USFirebird Biomolecular Sciences (United States) · US

Funding

Improved HIV Assays by Combining Four Innovations in Nucleic Acid ChemistryR01AI098616 · NIAID · FOUNDATION FOR APPLIED MOLECULAR EVOLUTN · PI BENNER, STEVEN A · 2012 to 2014
$1.1M
NIAID NIH HHS R01 AI098616
6 · The paper itself

Abstract

Nucleic acid (NA)-targeted tests detect and quantify viral DNA and RNA (collectively xNA) to support epidemiological surveillance and, in individual patients, to guide therapy. They commonly use polymerase chain reaction (PCR) and reverse transcription PCR. Although these all have rapid turnaround, they are expensive to run. Multiplexing would allow their cost to be spread over multiple targets, but often only with lower sensitivity and accuracy, noise, false positives, and false negatives; these arise by interactions between the multiple nucleic acid primers and probes in a multiplexed kit. Here we offer a multiplexed assay for a panel of respiratory viruses that mitigates these problems by combining several nucleic acid analogs from the emerging field of synthetic biology: (i) self-avoiding molecular recognition systems (SAMRSs), which facilitate multiplexing, and (ii) artificially expanded genetic information systems (AEGISs), which enable low-noise PCR. These are supplemented by "transliteration" technology, which converts standard nucleotides in a target to AEGIS nucleotides in a product, improving hybridization. The combination supports a multiplexed Luminex-based respiratory panel that potentially differentiates influenza viruses A and B, respiratory syncytial virus, severe acute respiratory syndrome coronavirus (SARS), and Middle East respiratory syndrome (MERS) coronavirus, detecting as few as 10 MERS virions in a 20-μl sample.

Indexed as

CoronaviridaeDeoxyribonucleosidesDNADNA-Directed RNA PolymerasesDNA, Single-StrandedFluorescent DyesHydrogen BondingImmobilized Nucleic AcidsLimit of DetectionMicrospheresMolecular TypingMultiplex Polymerase Chain ReactionNucleic Acid HeteroduplexesNucleic Acid HybridizationOrthomyxoviridaePhycoerythrin2-amino-8-(1'-(2'-deoxyribofuranosyl))imidazo(1,2-a)-1,3,5-triazin-4(8H)-one6-amino-5-nitro-3-(1'-(2'-deoxyribofuranosyl))-2(1H)-pyridonebacteriophage T7 RNA polymeraseDeoxyribonucleosidesDNADNA-Directed RNA PolymerasesDNA, Single-StrandedFluorescent DyesImmobilized Nucleic AcidsNucleic Acid HeteroduplexesPhycoerythrinPyridonesRNA, ViralTriazinesViral ProteinsArtificially expanded genetic information system (AEGIS)Luminex direct hybridization assayRespiratory virusesReverse transcription PCRSelf-avoiding molecular recognition system (SAMRS)

Identifiers

PMID26299645
PMCPMC4733849
OpenAlexW1878003436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.